Comparing a vibrating pelvic floor device to traditional vaginal dilators for treating entry dyspareunia
Official title: VIBRENT- VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia
Run by Medstar Health Research Institute · NCT06840314 · Data updated 2026-11-12
This study is testing whether a new vibrating pelvic floor device can help women with pain during sex feel better compared to using traditional vaginal dilators.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | Medstar Health Research Institute Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Status | Recruiting |
| Started | March 1, 2025 |
| Main results expected | November 2025 |
| Study ends | March 2026 |
| Registry record updated | May 21, 2025 |
| Trial ID | NCT06840314 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18 and older who have been diagnosed with genito-pelvic pain/penetration disorder.
✕Probably not a fit
Patients with unmanaged genitourinary syndrome of menopause or a history of pelvic radiation or genital tract malignancy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial evaluates the effectiveness of a novel vibrating pelvic floor therapeutic device, known as the 'Kiwi', in improving sexual function in sexually active women aged 18 and older with genito-pelvic pain and penetration disorder (GPPPD). Participants will be randomly assigned to use either the Kiwi device or traditional vaginal dilators three times a week for 15 minutes over four weeks. The study aims to determine if the Kiwi device leads to higher sexual function scores and greater improvements in sexual distress, pain, and overall symptom severity compared to traditional methods. Data will be collected using validated questionnaires at baseline and after the intervention period.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for women suffering from genito-pelvic pain and penetration disorders.
How similar studies have gone: While the use of vibrating devices for pelvic therapy is emerging, this specific approach comparing the Kiwi device to traditional dilators is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Assigned female at birth * Age ≥ 18 years old * Genito-pelvic pain/penetration disorder (per ICD-10 diagnosis codes: F52.5 Vaginismus not due to a substance or known physiological condition, F52.6 Dyspareunia not due to a substance or known physiological condition, N94.1 Dyspareunia, N94.2 Vaginismus, N94.81 Vulvodynia) Exclusion Criteria: * Current or prior use of a therapeutic vaginal device used to treat GPPPD * Unmanaged genitourinary syndrome of menopause * History of pelvic radiation * History of genital tract malignancy * History of female genital mutilation * History of prior surgery for prolapse or incontinence, including vaginal mesh or midurethral sling mesh * Silicone allergy
Where it's running
-
MedStar Health
Washington D.C., District of Columbia, United States Recruiting
Study contacts
- Principal investigator: Cheryl Iglesia, MD — Medstar Washington Hospital Center National Center for Advanced Pelvic Surgery
- Study coordinator: Helen Y Zhang, MD
- Email: helen.y.zhang@medstar.net
- Phone: 202-877-6526
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
12-week online pelvic health program for provoked vestibulodynia
This project will try a 12-week online pelvic health program to see if it reduces pain and improves sexual wellbeing for adults in North America with provoked vestibulodynia.
-
Pre-rehabilitation for women receiving pelvic radiation therapy
This study is testing if adding pelvic health physical therapy to radiation treatment can help women with certain cancers feel better and improve their quality of life.
-
Evaluating women's sexual quality of life after minimally invasive surgery for benign ovarian conditions
This study is testing if a new type of surgery for ovarian conditions affects women's sexual quality of life differently than traditional surgery.
-
Personalized Exercise Recommendations for Chronic Pelvic Pain
This study tests if an AI-powered, personalized exercise plan can help people with chronic pelvic pain see if tailored workouts work better than standard guidance.
-
Sexual Health in Spanish-Speaking Adults: A Large Online Survey
A large online survey will test sexual health, sexual behavior, and sexual function in Spanish-speaking adults to see how common these experiences are and to explore unusual states of consciousness during orgasm.
-
F-GYN injection for vaginal dryness and vaginal/vestibular atrophy
This study tests whether a one-time F-GYN injection can relieve vaginal dryness and related symptoms in adult women with atrophic vaginitis/vestibulovaginal atrophy compared with standard non-hormonal care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.